Sub"‘chronic Safety Evaluation of Ayurvedic Immunostimulant Formulation ‘Immuforte' in Rats in Reverse Pharmacology

Jump To References Section


  • ,IN
  • ,IN
  • ,IN
  • ,IN
  • ,IN
  • ,IN


Antioxidant, ayurveda, immunomodulation, stress, quality control


Objective: The present study was undertaken to determine target organ safety of "Immuforte” to establish relationship between dose or exposure and response and also to identify potential parameters for monitoring adverse effects of "Immuforte” in clinical studies, if any. Materials and Methods: A total of 40 males and 40 females were randomly assigned to the four groups, namely group I (vehicle control; gum acacia), group II (120 mg/kg BW of Immuforte in gum acacia), group III (360 mg/kg BW of Immuforte in gum acacia), and group IV (600 mg/kg BW of Immuforte in gum acacia) consisting of 10 males and 10 females in each group. Additionally, a recovery group (600 mg/kg BW of Immuforte in gum acacia) containing 5 males and 5 females was included. Results: The results showed significant decrease in percent lymphocyte count of high and mid dose groups as compared to control group. The percent neutrophil counts in all the three treated groups of male and female rats were found to be significantly higher than that of control group (P < 0.05). In females MCV values in low dose and mid dose were significantly higher as compared to control (P < 0.05). The males from low dose group showed significant decrease in total serum protein, globulin, electrolytes, direct bilirubin, creatinine levels, whereas in mid dose group along with albumin, globulin. A significant decrease in AST and cholesterol was observed. In females, significant decrease was observed in total protein and globulin of low dose and mid dose of Immuforte"‘treated rats (P < 0.05). Though few hematological and biochemical parameters were different from control group, no does related response was observed and further, all these values were comparable with historical control data of the colony. Terminal body weight, organ weight, gross, and histopathology did not reveal any toxicity"‘related any adverse effects. Heavy metal analysis of the blood samples collected from terminally sacrificed animals did not show presence of heavy metals viz. lead (Pb), mercury (Hg), cadmium (Cd), and arsenic (As). Conclusion: The results of the present study demonstrated that Immuforte does not cause any observable toxicity at doses used in the study when administered for the period of 90 days and is safe for the human use and thus, Immuforte could be used safely for therapeutic use in humans.


Download data is not yet available.



How to Cite

Dhumal, R., Patil, P., Selkar, N., Chawda, M., Vahlia, M., & Vanage, G. (2018). Sub"‘chronic Safety Evaluation of Ayurvedic Immunostimulant Formulation ‘Immuforte’ in Rats in Reverse Pharmacology. Toxicology International, 20(1), 87–94. Retrieved from



Original Research
Received 2018-08-09
Accepted 2018-08-09
Published 2018-08-09



Chopra A, Doiphode VV. Ayurvedic medicine. Core concept, therapeutic principles, and current relevance. Med Clin N Am 2002;86:75"‘89.

Asthana JG, Jain S, Mishra A, Vijaykant MS. Evaluation of antileprotic herbal drug combinations and their combination with Dapsone. Indian Drugs 2001;38:82"‘6.

Ikram M, Khattak SG, Gilani SN. Antipyretic studies on some indigenous Pakistani medicinal plants: II. J Ethnopharmacol 1987;19:185"‘92.

Nayampalli SS, Desai NK, Ainapure SS. Anti"‘allergic properties of Tinospora cordifolia in animal models. Indian J Pharmacol 1986;18:250"‘2.

Rai M, Gupta SS. The deposition of the secondary salts over the five pellets in rats was inhibited by the aqueous extract of T.cordifolia. J Res Indian Med 1966;10:113"‘6.

Pendse VK, Dadhich AP, Mathur PN, Bal MS, Madam BR.Anti"‘inflammatory, immunosuppressive and some related pharmacological actions of the water extract of Neem Giloe (Tinospora cordifolia)"‘A preliminary report. Indian J Pharm 1977;9:221"‘4.

Stanely M, Prince P, Menon VP. Antioxidant action of Tinospora cordifolia root extract in alloxan diabetic rats. Phytother Res 2001;15:213"‘8.

Mathew S, Kuttan G. Antioxidant activity of Tinospora cordifolia and its usefulness in the amelioration of cyclophosphamide induced toxicity. J Exp Clin Res 1997;16:407"‘11.

Prince PS, Menon VP. Antioxidant activity of Tinospora cordifolia roots in experimental diabetes. J Ethnopharmacol 1999;65:277"‘81.

Kapil A, Sharma S. Immunopotentiating compounds from Tinospora cordifolia. J Ethnopharmacol 1997;58:89"‘95.

Nagarkatti DS, Rege NN, Desai NK, Dahanukar SA. Modulation of Kupffer cell activity by Tinospora cordifolia in liver damage.J Postgrad Med 1994;40:65"‘7.

Rege N, Bapat RD, Koti R, Desai NK, Dahanukar S. Immunotherapy with Tinospora cordifolia: A new lead in the management of obstructive jaundice. Indian J Gastroenterol 1993;12:5"‘8.

Thatte UM, Dahanukar SA. Immunotherapeutic modification of experimental infections by Indian medicinal plants. Phytother Res 1989;3:43"‘9.

Thatte UM, Chhabria S, Karandikar SM, Dahanukar SA. Immunotherapeutic modification of E. coli induced abdominal sepsis and mortality in mice by Indian medicinal plants. Indian Drugs 1987;25:95"‘7.

Rege NN, Nazareth HM, Bapat RD, Dahanukar SA. Modulation of immunosuppression in obstructive jaundice by Tinospora cordifolia. Indian J Med Res 1989;90:478"‘83.

Manjrekar PN, Jolly CI, Narayanan S. Comparative studies of the immunomodulatory activity of Tinospora cordifolia and Tinospora sinensis. Fitoterapia 2000;71:254"‘7.

Dikshit V, Damre AS, Kulkarni KR, Gokhale A, Saraf MN.Preliminary screening of imunocin for immunomodulatory activity. Indian J Pharm Sci 2000;62:257"‘60.

Dahanukar SA, Thatte UM, Pai N, More PB, Karandikar SM.Immunotherapeutic modification by Tinospora cordifolia of abdominal sepsis induced by caecal ligation in rats. Indian J Gastroenterol 1988;7:21"‘3.

Rege NN, Thatte UM, Dahanukar SA. Adaptogenic properties of six rasayana herbs used in Ayurvedic medicine. Phytother Res 1999;13:275"‘91.

Thatte UM, Rao SG, Dahanukar SA. Tinospora cordifolia induces colony stimulating activity in serum. J Postgrad Med 1994;40:202"‘3.

Ghosal S, Lal J, Srivastava R, Bhattacharya SK, Upadhyay NS, Jaiswal AK, Chattopadhyay U. Immunomodulatory and CNS effects of sitoindosides IX and X, two new glycowithanolides from Withania somnifera. Phytother Res 1989;3:201"‘6.

Ziauddin M, Phansalkar N, Patki P, Diwanay S, Patwardhan B.Studies on the immunomodulatory effects of Ashwagandha.J Ethnopharmacol 1996;50:69"‘76.

Ames BN, Shigenaga MK, Hagen TM. Oxidants, antioxidants, and the degenerative diseases of aging. Proc Natl Acad Sci U S A 1993;90:7915"‘22.

Jesberger JA, Richardson JS. Oxygen free radicals and brain dysfunction. Int J Neurosci 1991;57:1"‘17.

Scarfiotti C, Fabris F, Cestaro B, Giuliani A. Free radicals, atherosclerosis, ageing, and related dysmetabolic pathologies: pathological and clinical aspects. Eur J Cancer Prev 1997;6 Suppl 1:S31"‘6.

Mishra LC, Singh BB, Dagenais S. Scientific basis for the therapeutic use of Withania somnifera (ashwagandha): A review.Alternat Med Rev 2000;5:334"‘46.

Sarkar PK, Das S, Prajapati PK. Ancient concept of metal pharmacology based on Ayurvedic literature. Anc Sci Life 2010;29:1"‘6.

Saper RB, Kales SN, Paquin J, Burns MJ, Eisenberg DM, Davis RB, et al. Heavy metal content of ayurvedic herbal medicine products. JAMA 2004;292:2868"‘73.

OECD. OECD guidelines for the testing of chemicals, Test guideline 408, Repeated Dose 90"‘day Oral Toxicity Study in Rodents. Paris: Organization for Economic Cooperation and Development, 1995.

Most read articles by the same author(s)